DGAP-News: SYNLAB AG / Key word(s): Acquisition
07.01.2022 / 08:00
The issuer is solely responsible for the content of this announcement.
– Sistemas Genómicos’ strong expertise in genetics – including bioinformatics, sequencing, molecular biology, and molecular genetics – will strategically complement SYNLAB’s already leading genetics service offering and expand SYNLAB’s leadership in specialty testing in Europe
– The integration of more than 100 highly-qualified professionals with extensive knowledge around technology and big data will enhance SYNLAB’s innovation power and strategic positioning in Spain and beyond
SYNLAB, Europe’s leading medical diagnostics services provider, today announced the acquisition of Valencia-based Sistemas Genómicos of the Ascires Group, a laboratory spezialized in genetics and bioinformatics. The acquisition will reinforce and complement SYNLAB’s expertise and capabilities in genetics and accelerate the digital transformation of its diagnostic service offering.
With expected revenue of approximately EUR 20 million[1] in 2021, Sistemas Genómicos is a…
